RAC2 and nonpapillary renal cell carcinoma: These data suggested that RAC2 may be involved in the immunosuppressive response in the tumor immune microenvironment of ccRCC; conversely, NEDD4L may inhibit tumorigenesis by promoting anti-tumor immunity.